[1] World Health Organization. Global tuberculosis report 2025. 2025. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2025. [2025-11-22].
[2] Kendall EA, Shrestha S, Dowdy DW. The epidemiological importance of subclinical tuberculosis. A critical reappraisal. Am J Respir Crit Care Med 2021;203(2):168 − 74. https://doi.org/10.1164/rccm.202006-2394PP.
[3] WHO. Report of the WHO consultation on asymptomatic tuberculosis. Geneva: WHO. 2025. https://www.who.int/publications/i/item/9789240106932.
[4] Frascella B, Richards AS, Sossen B, Emery JC, Odone A, Law I, et al. Subclinical tuberculosis disease—a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology. Clin Infect Dis 2021;73(3):e830 − 41. https://doi.org/10.1093/cid/ciaa1402.
[5] Xu YW, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, et al. High-resolution mapping of tuberculosis transmission: whole genome sequencing and phylogenetic modelling of a cohort from Valencia region, Spain. PLoS Med 2019;16(10):e1002961. https://doi.org/10.1371/journal.pmed.1002961.
[6] Stuck L, Klinkenberg E, Abdelgadir Ali N, Basheir Abukaraig EA, Adusi-Poku Y, Alebachew Wagaw Z, et al. Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis. Lancet Infect Dis 2024;24(7):726 − 36. https://doi.org/10.1016/S1473-3099(24)00011-2.
[7] National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis, Office of the Nationwide Epidemiological Sampling Survey for Tuberculosis. Report on nationwide random survey for the epidemiology of tuberculosis in 2000. Chin J Antituberc 2002;24(2):65 − 6. https://doi.org/10.3969/j.issn.1000-6621.2002.02.001.
[8] Technical Guidance Group of the Fifth National TB Epidemiological Survey, The Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc 2012;34(8):485 − 508. https://doi.org/10.19982/j.issn.1000-6621.2012.08.001.
[9] Ge SJ, Liu K, Jiang XN, Feng Z, Chen SH, Feng YL, et al. Prevalence, progression, and treatment of asymptomatic tuberculosis: a prospective cohort study in Lanxi County, Zhejiang Province, China. Open Forum Infect Dis 2025;12(5):ofaf275. https://doi.org/10.1093/ofid/ofaf275.
[10] Chen JO, Qiu YB, Rueda ZV, Hou JL, Lu KY, Chen LP, et al. Role of community-based active case finding in screening tuberculosis in Yunnan Province of China. Infect Dis Poverty 2019;8(1):92. https://doi.org/10.1186/s40249-019-0602-0.
[11] Tang PJ, Liang EM, Zhang XX, Feng YJ, Song HF, Xu JC, et al. Prevalence and risk factors of subclinical tuberculosis in a low-incidence setting in China. Front Microbiol 2022;12:731532. https://doi.org/10.3389/fmicb.2021.731532.
[12] Xin HN, Zhang HR, Yang SM, Liu JM, Lu W, Bai LQ, et al. 5-Year follow-up of active tuberculosis development from latent infection in rural China. Clin Infect Dis 2020;70(5):947 − 50. https://doi.org/10.1093/cid/ciz581.
[13] Xue MJ, Zhong JL, Gao M, Pan RL, Mo YQ, Hu YD, et al. Analysis of spatial-temporal dynamic distribution and related factors of tuberculosis in China from 2008 to 2018. Sci Rep 2023;13(1):4974. https://doi.org/10.1038/s41598-023-31430-0.
[14] Lu KY, Tang SD, Wu W, Li L, Yang R, Xu L. Analysis of tuberculosis case detection in key areas of Yunnan Province during 2015—2022. J Tuberc Lung Dis 2024;5(5):415 − 21. https://doi.org/10.19983/j.issn.2096-8493.2024115.